India Morning Newsletter, September 16-February 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

India Morning Newsletter, September 16

Sep 15, 2025 8:26 PM

To access a PDF version of this newsletter, please click here

If you would like to receive this newsletter via email, please

https://solutions.lseg.com/MNCIndia-Subscriptionpage

For an index of our newsletters click on

Previous page： Delaware judge says she will not block Metsera from ending Pfizer deal Next page： Cardiac muscle therapeutics firm Cytokinetics Q3 net loss widens

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Delaware judge says she will not block Metsera from ending Pfizer deal

Nov 5, 2025

WILMINGTON, Delaware, Nov 5 (Reuters) - A Delaware judge said on Wednesday she would reject a request by Pfizer ( PFE ) to temporarily block Metsera ( MTSR ) from terminating its takeover deal with Pfizer ( PFE ), allowing Metsera ( MTSR ) to proceed instead with a higher $10 billion deal from Novo Nordisk. ...

Cardiac muscle therapeutics firm Cytokinetics Q3 net loss widens

Nov 5, 2025

Overview * Cytokinetics ( CYTK ) Q3 net loss widens to $306.2 mln, driven by debt conversion expense * Company reports Q3 revenue of $1.9 mln, up from $0.5 mln last year * Cytokinetics ( CYTK ) prepares for potential U.S. launch of aficamten pending FDA approval Outlook * Company expects EMA decision on aficamten MAA in 1H 2026 *...

Jazz Pharmaceuticals Q3 revenue beats estimates

Nov 5, 2025

Overview * Jazz Pharmaceuticals ( JAZZ ) Q3 revenue grows 7% yr/yr, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting robust operational performance * Company narrows 2025 revenue guidance to $4.175 - $4.275 bln Outlook * Company narrows 2025 revenue guidance to $4.175 - $4.275 bln * Jazz Pharmaceuticals ( JAZZ ) expects top-line data from zanidatamab...

World Kinect Corporation Completes Acquisition of Universal Weather and Aviation's Trip Support Services Business

Nov 5, 2025

MIAMI--(BUSINESS WIRE)-- World Kinect Corporation ( WKC ) today announced that it has completed its previously announced acquisition of the Trip Support Services (TSS) division of Universal Weather and Aviation. Universal Weather, headquartered in Houston, Texas, has been a pioneer in trip support services with deep expertise in international travel regulations, logistics, and supply chain management. Its trip support business...